Jubilant Pharmova Limited has informed the Exchange regarding Appointment of Mr. Ashish Mukkirwar as Chief Financial Officer of the company w.e.f. May 23, 2026.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova's CFO Mr. Arun Kumar Sharma stepped down effective close of business on May 22, 2026, after his tenure, and has transitioned to the new role of Advisor to the Chairmen. The Board simultaneously approved the appointment of Mr. Ashish Mukkirwar as the new CFO and Key Managerial Personnel (KMP) effective May 23, 2026. Mukkirwar brings over 20 years of experience, having previously served as Group VP & CFO – Global Formulations Business at Glenmark Pharmaceuticals, and held senior roles at Moelis & Company and UBS Investment Banking. He holds an MBA from IIM Kolkata. The changes were approved based on recommendations from the Nomination, Remuneration and Compensation Committee and the Audit Committee.
The appointment of an experienced external CFO with a strong M&A and investor relations background could be viewed positively by the market, especially given the smooth internal transition where the outgoing CFO remains as an advisor.